Brief: Citadel Advisors Reports 6.4% Passive Stake In Atara Biotherapeutics As Of March 8 - SEC Filing
18/03/2024 20:25
March 18 (Reuters) - Atara Biotherapeutics Inc ATRA.O :
* CITADEL ADVISORS LLC REPORTS 6.4% PASSIVE STAKE IN ATARA
BIOTHERAPEUTICS INC AS OF MARCH 8 - SEC FILING
Source text for Eikon: ID:n0001104659-24-035552
Further company coverage: ATRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing